System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)

CompletedOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

January 1, 1999

Primary Completion Date

June 30, 2017

Study Completion Date

September 30, 2017

Conditions
Coronary Heart Disease
Interventions
PROCEDURE

Reperfusion

Trial Locations (23)

Unknown

Changshu First People's Hospital, Changshu

Changzhou Traditional Chinese Medicine Hospital, Changzhou

Jintan People's Hospital, Jintan

Liyang Hospital of TCM, Liyang

Gaochun People's Hospital, Nanjing

Anqing First People's Hospital, Anqing

The 123 Hospital of PLA, Bengbu

Changzhou Fouth People's Hospital, Changzhou

Huaian Second People's Hospital, Huai'an

Huainan Eastern Hospital, Huainan

Huainan Xinhua Hospital, Huainan

Maanshan Shiqiye Hospital, Ma’anshan

Muyang Traditional Chinese Medicine Hospital, Muyang

Nanjing First Hospital, Nanjing

Nanjing Pukou Central Hospital, Nanjing

Nnajing 81 Hospital, Nanjing

Nnajing Integrated Traditional Chinese and Westem Medicine Hospital, Nanjing

Taicang First People's Hospital, Taicang

Wuxi Third Hospital, Wuxi

Yixin People's Hospital, Wuxi

Yixing Traditional Chinese Medicine Hospital, Wuxi

Xuncheng Central Hospital, Xuancheng

Zhangjiagang First People's Hospital, Zhangjiagang

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT03051048 - System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study) | Biotech Hunter | Biotech Hunter